Format

Send to

Choose Destination
See comment in PubMed Commons below
N C Med J. 2013 Nov-Dec;74(6):494-8.

Direct-to-consumer genomic testing offers little clinical utility but appears to cause minimal harm.

Author information

1
Corresponding author: Arthur S. Aylesworth, University of North Carolina at Chapel Hill, CB 7487, Chapel Hill, NC 27599, USA. asayls@med.unc.edu.

Abstract

Direct-to-consumer genomic testing is available to anyone willing to pay for it. We investigated the reliability and reproducibility of such testing by sending DNA samples to 2 popular companies and by reviewing current literature on this topic. The concerns that were initially raised about direct-to- consumer genomic testing still seem valid.

PMID:
24316774
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for North Carolina Institute of Medicine
    Loading ...
    Support Center